Search

everythinglearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

Alopecia areata involves unique activation of certain immune cells.

Intralesional cidofovir might be a good alternative treatment.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Enhancing Tregs can protect against alopecia areata.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

CD44 variant changes start alopecia areata, but don't maintain it.

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

Blood count parameters are not reliable for predicting recurrent implantation failure.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Understanding the 2D:4D digit ratio in vitiligo patients may help in clinical assessments.

IL-17 and certain immune cells are linked to more severe alopecia areata.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Dual TCR Treg cells are common in mouse tissues and vary by location.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Hematological ratios can effectively predict and manage alopecia areata severity.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.